Strong team including some from Sirtex , TLX Telix Pharmaceutical Limited , around a $4.5 billion market cap but in my opinion the main play here is market acceptance. I do not think more sales is the main play here and that this is being primed for a take over with a larger pharma who can monetize this device much better than Oncosil. I think Oncosil know this, interesting times ahead.There are Biotechs in Phase 1 or pre clinical with larger market caps.
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-84
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $191.9K | 21.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 8525000 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 964494 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |